Artículos por temáticas

Old stuff still trending: use of propafenone as a safety net until catheter ablation in a patient with documented pre-excited atrial fibrillation and Wolff-Parkinson-White syndrome - a classic case report

Karelas D, Papanikolaou J, Kossyvakis C, Platogiannis D.

Eur Heart J Case Rep. 2021 Nov 30;5(12):ytab485. doi: 10.1093/ehjcr/ytab485. eCollection 2021 Dec.

Correction to: Orally delivered water soluble coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease

Muthukumaran K, Leahy S, Harrison K, Sikorska M, Sandhu JK, Cohen J, Keshan C, Lopatin D, Miller H, Borowy-Borowski H, Lanthier P, Weinstock S, Pandey S.

BMC Neurosci. 2021 Dec 20;22(1):79. doi: 10.1186/s12868-021-00684-7.

Correction to "A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease"

Kwon SH, Kim S, Park AY, Lee S, Gadhe CG, Seo BA, Park JS, Jo S, Oh Y, Kweon SH, Ma SX, Kim WR, Kim M, Kim H, Kim JE, Lee S, Lee J, Ko HS.

J Med Chem. 2021 Dec 23;64(24):18237. doi: 10.1021/acs.jmedchem.1c01988. Epub 2021 Dec 2.

Lower Circulating Lymphocyte Count Predicts ApoE ε4-Related Cognitive Decline in Parkinson's Disease

Tsukita K, Sakamaki-Tsukita H, Takahashi R.

Mov Disord. 2021 Dec;36(12):2969-2971. doi: 10.1002/mds.28799. Epub 2021 Oct 13.

Does Cognitive Impairment Influence Motor Speech Performance in De Novo Parkinson's Disease?

Rusz J, Tykalová T.

Mov Disord. 2021 Dec;36(12):2980-2982. doi: 10.1002/mds.28836.

Citius, Fortius, Altius-Understanding Which Components Drive Exercise Benefits in Parkinson Disease

de Vries NM, Darweesh SKL, Bloem BR.

JAMA Neurol. 2021 Dec 1;78(12):1443-1445. doi: 10.1001/jamaneurol.2021.3744.

The significance of the loss of presynaptic inhibition for step initiation in parkinsonian individuals with freezing of gait

Onder H, Kocer B, Comoglu S.

J Physiol. 2021 Dec 2. doi: 10.1113/JP282365. Online ahead of print.

Measuring Tremor-A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating

Fois AF, Mahant N, Vucic S, Fung VSC.

Mov Disord. 2021 Dec;36(12):2962-2963. doi: 10.1002/mds.28776. Epub 2021 Sep 2.

Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease

Maass F, Michalke B, Willkommen D, Canaslan S, Schmitz M, Bähr M, Zerr I, Lingor P.

Mov Disord. 2021 Dec;36(12):2967-2969. doi: 10.1002/mds.28790. Epub 2021 Sep 23.

Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation

Ghiglieri V, Natale G.

Mov Disord. 2021 Dec;36(12):2979-2980. doi: 10.1002/mds.28830.

Rest Tremor Pattern Predicts DaTscan ((123) I-Ioflupane) Result in Tremulous Disorders

Quattrone A, Nisticò R, Morelli M, Arabia G, Crasà M, Vescio B, Mechelli A, Cascini GL, Quattrone A.

Mov Disord. 2021 Dec;36(12):2964-2966. doi: 10.1002/mds.28797. Epub 2021 Sep 28.

Letter to the editor, "High intensity aerobic exercise improves bimanual coordination of grasping forces in Parkinson's disease"

Mondal M, Sharma N, Samuel AJ.

Parkinsonism Relat Disord. 2021 Dec;93:105-106. doi: 10.1016/j.parkreldis.2021.11.005. Epub 2021 Nov 19.

Screening of GBA Mutations in Nigerian Patients with Parkinson's Disease

Milanowski LM, Oshinaike O, Walton RL, Soto-Beasley AI, Hanna Al-Shaikh R, Strongosky AJ, Ross OA, Wszolek ZK, Ogun SA.

Mov Disord. 2021 Dec;36(12):2971-2973. doi: 10.1002/mds.28803. Epub 2021 Sep 29.

Author Correction: Comparison of cognitive performance between patients with Parkinson's disease and dystonia using an intraoperative recognition memory test

Shi L, Yuan T, Fan S, Diao Y, Qin G, Liu D, Zhu G, Qin K, Liu H, Zhang H, Yang A, Meng F, Zhang J.

Sci Rep. 2021 Dec 27;11(1):24525. doi: 10.1038/s41598-021-04332-2.

Parkinson's disease with a typical clinical course of 17 years overlapped by Creutzfeldt-Jakob disease: an autopsy case report

Kubo SI, Matsubara T, Taguchi T, Sengoku R, Takeuchi A, Saito Y.

BMC Neurol. 2021 Dec 10;21(1):480. doi: 10.1186/s12883-021-02504-1.